The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 15,301–15,400 of 31,469
Kalimeri, M., Leek, F. A. A., Wang, N. X., Koh, H. R., Roy, N. C., Cameron‐Smith, D., Kruger, M. C., Henry, C. J., & Totman, J. J. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15050889 · Cited by 20
Wang, J., Xu, L., Xia, H., Li, Y., & Tang, S. (2018) · Journal of International Medical Research · doi:10.1177/0300060518768969 · Cited by 20
Argo, C. K., Stine, J. G., Henry, Z. H., Lackner, C., Patrie, J. T., WELTMAN, A. L., & Caldwell, S. H. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14803 · Cited by 19
Generoso, G., Benseñor, I. M., Santos, R. D., Santos, I. S., Goulart, A. C., Jones, S. R., Kulkarni, K. R., Blaha, M. J., Toth, P. P., Lotufo, P. A., et al. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.05.003 · Cited by 20
Zhang, D., Du, Q., Djemli, A., Julien, P., Fraser, W. D., & Luo, Z. (2018) · Diabetic Medicine · doi:10.1111/dme.13671 · Cited by 20
Wu, Y., Zhang, L., Liang, J., Jiang, Q., Guo, Y., & Lan, G. (2018) · Gene · doi:10.1016/j.gene.2018.06.014 · Cited by 20
Veeramani, C., Alsaif, M. A., & Al‐Numair, K. S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.121 · Cited by 20
Zuk, A. M., Quiñonez, C., Saarela, O., Demmer, R. T., & Rosella, L. C. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000535 · Cited by 20
Insulin Resistance Probability Scores for Apparently Healthy Individuals
Abbasi, F., Shiffman, D., Tong, C. H., Devlin, J. J., & McPhaul, M. J. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00107 · Cited by 20
Yao, J., Kovalik, J., Lai, O. F., Lee, P. C., Eng, A. K. H., Chan, W. H., Tham, K. W., Lim, E. K. W., Bee, Y. M., & Tan, H. C. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3487-2 · Cited by 20
Hepatic fat and glucose tolerance in women with recent gestational diabetes
Mehmood, S., Margolis, M., Ye, C., Maple-Brown, L. J., Hanley, A. J., Connelly, P. W., Sermer, M., Zinman, B., & Retnakaran, R. R. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000549 · Cited by 20
Wang, Y., Zheng, X., Xie, X., Qian, W., Zhang, L., & Ren, W. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0541 · Cited by 21
Metformin improves ovarian insulin signaling alterations caused by fetal programming
Heber, M. F., Ferreira, S. R., Abruzzese, G. A., Raices, T., Pignataro, O. P., Vega, M., & Motta, A. B. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0520 · Cited by 20
Difference of Glucose variability between Low Carbohydrate Diet (LCD) and Calorie Restriction (CR)
Bando, H., Ebe, K., Muneta, T., Bando, M., & Yonei, Y. (2019) · Asploro Journal of Biomedical and Clinical Case Reports · doi:10.36502/2019/asjbccr.6142 · Cited by 22
Bochud, M., Ponte, B., Pruijm, M. T., Ackermann, D., Guessous, I., Ehret, G., Escher, G., Groessl, M., Younes, S. E., d’Uscio, C. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01942 · Cited by 21
Increased Arterial Stiffness in Adolescents With Obesity
Lentferink, Y. E., Kromwijk, L. A. J., van der Aa, M. P., Knibbe, C. A. J., & van der Vorst, M. M. J. (2019) · Global Pediatric Health · doi:10.1177/2333794x19831297 · Cited by 20
Arora, G. P., Åkerlund, M., Brøns, C., Moen, G.-H., Wasenius, N., Sommer, C., Jenum, A. K., Almgren, P., Thaman, R. G., Orho‐Melander, M., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12903 · Cited by 20
Townsend, D. K., Deysher, D. M., Wu, E. E., et al. (2019) · Experimental Physiology · doi:10.1113/ep087216 · Cited by 20
Soontornniyomkij, V., Lee, E. E., Jin, H., Martin, A., Daly, R., Liu, J., Tu, X., Eyler, L., & Jeste, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00251 · Cited by 19
Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome
Demir, I. E., Güler, A., Alarslan, P., Işıl, A. M., Ucman, O., Aslanıpour, B., & Çalan, M. (2019) · Endocrine · doi:10.1007/s12020-019-01972-3 · Cited by 20
Circulating adipokines and metabolic setting in differentiated thyroid cancer
Mele, C., Samà, M. T., Bisoffi, A. A., Caputo, M., Bullara, V., Mai, S., Walker, G. E., Prodam, F., Marzullo, P., Aimaretti, G., et al. (2019) · Endocrine Connections · doi:10.1530/ec-19-0262 · Cited by 21
Mercurio, V., Pucci, G., Bosso, G., Fazio, V., Battista, F., Iannuzzi, A., Brambilla, N., Vitalini, C., D’Amato, M., Giacovelli, G., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.06.026 · Cited by 22
Mengen, E., Uçaktürk, S. A., Kocaay, P., Kaymaz, Ö., Neşeli̇oğlu, S., & Erel, Ö. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2019.2019.0039 · Cited by 20
Li, X., Wang, F., Xu, H., Qian, Y., Zou, J., Yang, M., Zhu, H., Yi, H., Guan, J., & Yin, S. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.07.016 · Cited by 20
Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitis
Dey, P., Kim, J. B., Chitchumroonchokchai, C., Li, J., Sasaki, G. Y., Olmstead, B. D., Stock, K. L., Thomas‐Ahner, J. M., Clinton, S. K., & Bruno, R. S. (2019) · Food & Function · doi:10.1039/c9fo01199d · Cited by 20
Yu, H., Wang, T., Zhang, R., Yan, J. Y., Jiang, F., Li, S., Jia, W., & Hu, C. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0396-x · Cited by 22
Ramos-López, O., Riezu‐Boj, J. I., Milagro, F. I., Cuervo, M., Goñi, L., & Martínez, J. A. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819877303 · Cited by 20
van Raan, A. F. J., & Winnink, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223373 · Cited by 20
Schellong, K., Melchior, K., Ziska, T., Henrich, W., Rancourt, R. C., & Plagemann, A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108257 · Cited by 21
Ramos-López, O., Riezu‐Boj, J. I., Milagro, F. I., Cuervo, M., Goñi, L., & Martínez, J. A. (2019) · Nutrients · doi:10.3390/nu12010033 · Cited by 20
Sweeney, E. L., Peart, D. J., Kyza, I., Harkes, T., Ellis, J. G., & Walshe, I. H. (2019) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2019-0235 · Cited by 21
Hussein, J., El‐Naggar, M. E., Badawy, E. A., El-Laithy, N. A., El-Wassef, M., Hassan, H., & Abdel‐Latif, Y. (2020) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-020-03230-z · Cited by 20
Johnston, E. A., Petersen, K. S., & Kris‐Etherton, P. M. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520000252 · Cited by 20
Exercise improves metformin 72-h glucose control by reducing the frequency of hyperglycemic peaks
ORTEGA, J. F., Morales‐Palomo, F., Ramírez-Jiménez, M., Moreno‐Cabañas, A., & Mora‐Rodríguez, R. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01488-7 · Cited by 22
The endocrine manifestations of spinal muscular atrophy, a real-life observational study
Brener, A., Lebenthal, Y., Shtamler, A., Levy, S., Stein, R., Fattal‐Valevski, A., & Sagi, L. (2020) · Neuromuscular Disorders · doi:10.1016/j.nmd.2020.02.011 · Cited by 22
Segura-Cerda, C. A., Marquina‐Castillo, B., Lozano-Ordaz, V., Mata‐Espinosa, D., Barrios‐Payán, J., López-Torres, M. O., Aceves-Sánchez, M. D. J., Bielefeldt‐Ohmann, H., Hernández‐Pando, R., & Flores‐Valdez, M. A. (2020) · npj Vaccines · doi:10.1038/s41541-020-0169-6 · Cited by 20
Oriolo, C., Fanelli, F., Castelli, S., Mezzullo, M., Altieri, P., Corzani, F., Pelusi, C., Repaci, A., Dalmazi, G. D., Vicennati, V., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01235-3 · Cited by 20
Saad, Z. A., Khodeer, D. M., Zaitone, S. A., Ahmed, A. A. M., & Moustafa, Y. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117725 · Cited by 20
Unique Metabolic Features of Adults Discordant for Indices of Insulin Resistance
Song, Y., Søndergaard, E., & Jensen, M. D. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa265 · Cited by 20
Kamble, P. G., Theorell‐Haglöw, J., Wiklund, U., Franklin, K. A., Hammar, U., Lindberg, E., & Eriksson, J. W. (2020) · Endocrine · doi:10.1007/s12020-020-02369-3 · Cited by 21
Wetherell, J. L., Ripperger, H. S., Voegtle, M. L., Ances, B. M., Balota, D. A., Bower, E. S., Depp, C. A., Eyler, L. T., Foster, E. R., Head, D. M., et al. (2020) · Clinical Trials · doi:10.1177/1740774520931864 · Cited by 24
Martini, D., Rosi, A., Tassotti, M., Antonini, M., Dall’Asta, M., Bresciani, L., Fantuzzi, F., Spigoni, V., Domínguez‐Perles, R., Angelino, D., et al. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02347-5 · Cited by 21
Chartrand, D. J., Larose, É., Poirier, P., Mathieu, P., Alméras, N., Pîbarot, P., Lamarche, B., Rhéaume, C., & Després, J. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00251.2020 · Cited by 20
Zou, H., Xu, Y., Chen, X., Yin, P., Li, D., Li, W., Xie, J., Shao, S., Liu, L., & Yu, X. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01103-7 · Cited by 21
Obstructive sleep apnea and severity of nonalcoholic fatty liver disease
Krolow, G. K., Garcia, E., Schorr, F., Araujo, F. B. S., & Coral, G. P. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001920 · Cited by 21
DNA methylation of FKBP5 in South African women: associations with obesity and insulin resistance
Willmer, T., Goedecke, J. H., Dias, S. C., Louw, J., & Pheiffer, C. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00932-3 · Cited by 21
Brener, A., Sagi, L., Shtamler, A., Levy, S., Fattal‐Valevski, A., & Lebenthal, Y. (2020) · Neuromuscular Disorders · doi:10.1016/j.nmd.2020.09.025 · Cited by 22
Magill, L., Lämmer, C., Woelfle, J., Fimmers, R., & Gohlke, B. C. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01527-0 · Cited by 20
Hernández‐Conde, M., Llop, E., Fernández‐Carrillo, C., Tormo, B., Abad, J., Luis, R., Perelló, C., Gomez, M. L., Porras, J. L. M., Puga, N. F., et al. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i42.6658 · Cited by 20
Nunes, Â. A., Buccini, D. F., Jaques, J. A. D. S., Portugal, L. C., Guimarães, R. C. A., Favaro, S. P., Caldas, R. D. A., & Carvalho, C. M. E. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104295 · Cited by 20
Rasouli, N., Younes, N., Utzschneider, K. M., Inzucchi, S. E., Balasubramanyam, A., Cherrington, A., Ismail‐Beigi, F., Cohen, R. M., Olson, D. E., DeFronzo, R. A., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1787 · Cited by 21
Early Predictors of Gestational Diabetes Mellitus in IVF-Conceived Pregnancies
Coussa, A., Hasan, H. A., & Barber, T. M. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.10.020 · Cited by 21
LeCroy, M. N., Strizich, G., Gallo, L. C., Perreira, K. M., Ayala, G. X., Carnethon, M. R., Delamater, A. M., Gonzalez, J. S., Arredondo, E. M., Pulgarón, E. R., et al. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaa114 · Cited by 20
Sánchez‐Delgado, G., Martínez‐Téllez, B., Acosta, F. M., Virtue, S., Vidal‐Puig, A., Gil, Á., Elvira, J. M. L., & Ruiz, J. R. (2021) · Diabetes · doi:10.2337/db21-0011 · Cited by 20
Obesity-Related Hypertension in Pediatrics, the Impact of American Academy of Pediatrics Guidelines
Rutigliano, I., FILIPPO, G. D., Pastore, L., Messina, G., Agostoni, C. V., & Campanozzi, A. (2021) · Nutrients · doi:10.3390/nu13082586 · Cited by 24
Eley, V. A., Thuzar, M., Navarro, S., Dodd, B. R., & van Zundert, A. A. J. (2021) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2021.100947 · Cited by 22
Wong, J. M., Yu, S., Ma, C., Mehta, T. S., Dickinson, S., Allison, D. B., Heymsfield, S. B., Ebbeling, C. B., & Ludwig, D. S. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab315 · Cited by 23
Hilton, C., Vasan, S. K., Neville, M. J., Christodoulides, C., & Karpe, F. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2008238 · Cited by 20
Berezin, A. A., Lichtenauer, M., Boxhammer, E., Fushtey, I. M., & Berezin, A. Е. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.922775 · Cited by 22
Gambineri, A., Patton, L., Prontera, O., Fanelli, F., Ciampaglia, W., Cognigni, G. E., Pagotto, U., & Pasquali, R. (2011) · PubMed · doi:10.3275/7726 · Cited by 20
Role of leptin G-2548A polymorphism in age- and gender-specific development of obesity
Shahid, A., Rana, S., Mahmood, S., & Saeed, S. (2015) · Journal of Biosciences · doi:10.1007/s12038-015-9536-2 · Cited by 20
Fountaine, M. F. L., Cirnigliaro, C. M., Emmons, R. R., Kirshblum, S., Galea, M., Spungen, A. M., & Bauman, W. A. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0084-4 · Cited by 22
Kain, K., Carter, A. M., Grant, P. J., et al. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02935.x · Cited by 20
Guilder, G. P. V., Hoetzer, G. L., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.151555 · Cited by 20
Physical Activity and Its Association with Insulin Resistance in Multicenter AIDS Cohort Study Men
Monroe, A. K., Brown, T. T., Cox, C., Reynolds, S. M., Wiley, D. J., Palella, F. J., Kingsley, L., & Plankey, M. W. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0027 · Cited by 21
Kim, S. H., Abbasi, F., Lamendola, C. A., Reaven, G. M., & McLaughlin, T. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0183-2 · Cited by 21
The relation between long‐term cortisol levels and the metabolic syndrome in HIV ‐infected patients
Langerak, T., van den Dries, L. W. J., Wester, V. L., Staufenbiel, S. M., Manenschijn, L., van Rossum, E. F. C., & Gorp, E. C. M. V. (2015) · Clinical Endocrinology · doi:10.1111/cen.12790 · Cited by 20
UNDERWOOD, P. C., Sun, B., Williams, J. S., Pojoga, L. H., Raby, B. A., Lasky-Su, J. A., Hunt, S. C., Hopkins, P. N., Jeunemaı̂tre, X., Adler, G. K., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.009 · Cited by 19
Katsuda, Y., Asano, A., Murase, Y., Chujo, D., Yagi, K., Kobayashi, J., Mabuchi, H., & Yamagishi, M. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14.19 · Cited by 20
Saleh, A., Amanatidis, S., & Samman, S. (2002) · Asia Pacific Journal of Clinical Nutrition · doi:10.1046/j.1440-6047.2002.00293.x · Cited by 20
Tonucci, L. B., Mourão, D. M., Ribeiro, A. Q., & Bressan, J. (2014) · Aesthetic Plastic Surgery · doi:10.1007/s00266-014-0391-6 · Cited by 20
The Biological Variation of C-Reactive Protein in Polycystic Ovarian Syndrome
Cho, L. W., Jayagopal, V., Kilpatrick, E. S., & Atkin, S. L. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.052753 · Cited by 20
Gradillas-García, A., Álvarez, J., Rubio, J. A., & de Abajo, F. J. (2015) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2015.04.004 · Cited by 20
Energy restriction in obese subjects impact differently two mitochondrial function markers
Crujeiras, A. B., Parra, D., Goyenechea, E., Abete, I., González‐Muniesa, P., & Martínez, J. A. (2008) · Journal of Physiology and Biochemistry · doi:10.1007/bf03178844 · Cited by 20
Frelut, M., Fillon-Emery, N., Guilland, J.-C., Dao, H. H., & de Courcy, G. P. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000228110.83616.92 · Cited by 20
Ebert, T., Hindricks, J., Kralisch, S., Lössner, U., Jeßnitzer, B., Richter, J., Blüher, M., Stümvoll, M., & Faßhauer, M. (2014) · Diabetic Medicine · doi:10.1111/dme.12451 · Cited by 20
Francischetti, E. A., Celoria, B. M. J., Duarte, S. F. P., da Silva, E. G., Santos, I. J., Cabello, P. H., & Genelhu, V. A. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.011 · Cited by 20
Randomized controlled trial of Sajabalssuk (Artemisia princeps Pampanini) to treat pre-diabetes
Cho, Y.-Y., Baek, N., Chung, H., Jeong, T., Lee, K., Jeon, S.-M., Kim, H.-J., McGregor, R. A., & Choi, M. (2012) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2012.01.009 · Cited by 20
Primary Hyperparathyroidism, Insulin Resistance, and Cardiovascular Disease: A Review
Ybarra, J., Doñate, T., Jurado, J., & Pou, J. M. (2007) · Nursing Clinics of North America · doi:10.1016/j.cnur.2006.11.010 · Cited by 20
Kalaitzakis, E., Josefsson, A., Castedal, M., Henfridsson, P., Bengtsson, M., Andersson, B. A., & Bjornsson, E. S. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.836755 · Cited by 20
Karne, R. J., Chen, H., & Quon, M. J. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1247-a · Cited by 20
Potau, N., Williams, R. M., Ong, K. K., Sánchez-Ufarte, C., de Zegher, F., Ibáñez, L., & Dunger, D. B. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01919.x · Cited by 20
Association Between Serum Vaspin Level and Metabolic Syndrome in Healthy Korean Subjects
Kim, J. M., Kim, T. N., & Won, J. C. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0054 · Cited by 20
Metabolic Syndrome: Historical Perspectives
Leslie, B. R. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00002 · Cited by 20
Franco‐Sena, A. B., de Oliveira, L. C., Pinto, T., Farias, D. R., Vaz, J. D. S., & Kac, G. (2014) · Clinical Endocrinology · doi:10.1111/cen.12487 · Cited by 20
Insulin resistance is independently related to age in Mexican women
Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345121 · Cited by 20
The role of feed regulating peptides on weight loss in patients with pulmonary tuberculosis
Yurt, S., Erman, H., Korkmaz, G. G., et al. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.09.008 · Cited by 20
Karadeniz, M., Erdoğan, M., Berdeli, A., Saygılı, F., & Yılmaz, C. (2007) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-007-9160-7 · Cited by 20
Inuit anthropometry and insulin resistance
Charbonneau, G., Young, K., & Egeland, G. M. (2007) · International Journal of Circumpolar Health · doi:10.3402/ijch.v66i2.18242 · Cited by 20
Obese children without comorbidities have impaired microvascular endothelial function
Kallerman, P. H., Hagman, E., Bonamy, A. E., Zemack, H., Marcus, C., Norman, M., & Westerståhl, M. (2013) · Acta Paediatrica · doi:10.1111/apa.12549 · Cited by 20
Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure
Ohara, T., Hashimura, K., Asakura, M., Ogai, A., Amaki, M., Hasegawa, T., Kanzaki, H., Sonoda, M., Nishizawa, H., Funahashi, T., et al. (2011) · Journal of Cardiology · doi:10.1016/j.jjcc.2011.06.010 · Cited by 20
Small Birth Size, Adult Overweight, and Risk of Acute Myocardial Infraction
Rajaleid, K., Janszky, I., & Hallqvist, J. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181fe1e74 · Cited by 20
Voruganti, V. S., Cai, G., Klohe-Lehman, D. M., Jordan, K. C., Lane, M. A., & FREELAND-GRAVES, J. H. (2010) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2010.05.001 · Cited by 20
Kawamoto, R., Tabara, Y., Kohara, K., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.6379 · Cited by 20
MANDERS, R. J. F., Pennings, B., Beckers, C. P., Aipassa, T. I., & van Loon, L. J. C. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27072 · Cited by 19
Vimaleswaran, K. S., Radha, V., Ghosh, S., et al. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0039 · Cited by 20
Zheng, T., Gao, Y., & Tian, H. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-634 · Cited by 20
Shimabukuro, M., Higa, N., Asahi, T., Oshiro, Y., & Takasu, N. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.018 · Cited by 20
Novaković, T., Mekić, M., Smilic, L., Smilic, T. N., Ini, B., Kostic, K., Jovićević, L., Mirković, Z., & Milinić, S. (2014) · Medical Archives · doi:10.5455/medarh.2014.68.22-26 · Cited by 20
López-Ríos, L., Pérez-Jiménez, P., Martínez‐Quintana, E., Rodríguez-González, F. G., Díaz-Chico, B. N., Novoa, F. J., Serra‐Majem, L., & Chirino, R. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.06.009 · Cited by 20
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
